Skip to main content

Select Drug Profiles

FDA Approvals
Tofidence, First Biosimilar to Actemra, FDA Approved for Rheumatoid Arthritis and 2 Forms of Juvenile Idiopathic Arthritis
Read More
FDA Approvals
FDA Approved Rivfloza for Treatment of Primary Hyperoxaluria Type 1 in Children and Adults
Read More
FDA Approvals
Braftovi Plus Mektovi Now FDA Approved for Treatment of Metastatic Non–Small Cell Lung Cancer With BRAF Mutation
Read More
FDA Approvals
Opdivo Now Approved for Adjuvant Treatment of Stage IIB/C Melanoma
Read More
FDA Approvals
Keytruda Now Approved for Neoadjuvant and Adjuvant Treatment of Resectable Non–Small Cell Lung Cancer
Read More
Online Only
Oncology, Original Research
The Hidden Inferno: Burn Pit Exposure in the Military and Its Potential Links to Cancer
Claire Szewczyk
Claire Szewczyk
Read More
Introduction
Welcome to the 2023 PAYERS’ GUIDE TO FDA UPDATES: Latest Approvals, Upcoming Decisions
Read More
A Payer Perspective
Challenges Facing the US Healthcare System in 2023 and Beyond: A Payer Perspective
Gary M. Owens, MD
Gary M. Owens, MD
Read More
FDA Approvals
IMJUDO (Tremelimumab-actl) in Combination With IMFINZI (Durvalumab) Receives FDA Approval for HCC and NSCLC
Jerm Day-Storms, PhD, MWC
Read More
FDA Approvals
FDA Pipeline, October-December 2023
Read More
Page 8 of 244
Results 71 - 80 of 2438